Second Photo
fundable.
DATA PLATFORM
  • Dashboard
  • Companies
  • People
  • Investment Firms
  • Angels & Partners
COLLECTIONS
  • Lists
  • Saved Searches
  • Hiring Lists
WORKFLOWS
  • Deal Alerts
  • Integrations
  • API + Credits


logo
Sibylla Biotech logo

Sibylla Biotech

Recent Finacing

Series A

Recent Raise

$22.6M

Sibylla Biotech designs small-molecule Folding Interfering Degraders using PPI‑FIT to bind protein folding intermediates and induce degradation, focusing on Cyclin D1 and expanding a folding simulation platform.

Founded 2017
Trentino-Alto Adige, Italy
11-50
Private
sibyllabiotech.it

Highlights

Focus Areas

Biotechnology
Health Care
Medical
Pharmaceutical

Recent Investors

V-Bio Ventures logo
Vertis SGR logo
CDP Venture Capital logo
3B Future Health Fund logo
Claris Ventures logo
Seroba Life Sciences logo
VI Partners logo
Indaco Venture Partners logo

Financials

$22.6M

Total Raised

1

Funding round

8

Investors


Team

Upgrade to view the team

See the team members at Sibylla Biotech.